Ghana's simultaneous introduction of pneumococcal and rotavirus vaccines 09

in page functions
09 Ghana Doune Porter PATH 2012

February 2012. Ghana – Paul Bediako, Ghana’s National Cold Chain Manager, in one of Accra’s walk-in cold rooms with the pneumococcal vaccines that will be introduced in Ghana, along with rotavirus vaccines in an unprecedented joint launch on April 26, 2012.

Photo: GAVI/Doune Porter/PATH/2012

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here